BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Costa CP, Barreiro S, Moreira JN, Silva R, Almeida H, Sousa Lobo JM, Silva AC. In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN). Pharmaceuticals (Basel) 2021;14:711. [PMID: 34451808 DOI: 10.3390/ph14080711] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Matias M, Santos AO, Silvestre S, Alves G. Fighting Epilepsy with Nanomedicines—Is This the Right Weapon? Pharmaceutics 2023;15:306. [DOI: 10.3390/pharmaceutics15020306] [Reference Citation Analysis]
2 Szaleniec J, Gibała A, Stalińska J, Oćwieja M, Żeliszewska P, Drukała J, Szaleniec M, Gosiewski T. Biocidal Activity of Tannic Acid-Prepared Silver Nanoparticles towards Pathogens Isolated from Patients with Exacerbations of Chronic Rhinosinusitis. Int J Mol Sci 2022;23. [PMID: 36499763 DOI: 10.3390/ijms232315411] [Reference Citation Analysis]
3 Said DE, Amer EI, Sheta E, Makled S, Diab HE, Arafa FM. Nano-Encapsulated Melatonin: A Promising Mucosal Adjuvant in Intranasal Immunization against Chronic Experimental T. gondii Infection. Trop Med Infect Dis 2022;7. [PMID: 36548656 DOI: 10.3390/tropicalmed7120401] [Reference Citation Analysis]
4 Silva AC, Moreira JN, Lobo JMS. Editorial-Current Insights on Lipid-Based Nanosystems. Pharmaceuticals (Basel) 2022;15:1267. [PMID: 36297379 DOI: 10.3390/ph15101267] [Reference Citation Analysis]
5 Correia AC, Monteiro AR, Silva R, Moreira JN, Sousa Lobo JM, Silva AC. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders. Adv Drug Deliv Rev 2022;189:114485. [PMID: 35970274 DOI: 10.1016/j.addr.2022.114485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 de Barros C, Portugal I, Batain F, Portella D, Severino P, Cardoso J, Arcuri P, Chaud M, Alves T. Formulation, design and strategies for efficient nanotechnology-based nasal delivery systems. RPS Pharmacy and Pharmacology Reports 2022;1. [DOI: 10.1093/rpsppr/rqac003] [Reference Citation Analysis]
7 Chavda VP, Jogi G, Shah N, Athalye MN, Bamaniya N, K Vora L, Cláudia Paiva-santos A. Advanced particulate carrier-mediated technologies for nasal drug delivery. Journal of Drug Delivery Science and Technology 2022;74:103569. [DOI: 10.1016/j.jddst.2022.103569] [Reference Citation Analysis]
8 Domingues C, Santos A, Alvarez-Lorenzo C, Concheiro A, Jarak I, Veiga F, Barbosa I, Dourado M, Figueiras A. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology. ACS Nano 2022. [PMID: 35729778 DOI: 10.1021/acsnano.2c00128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
9 Pinto M, Silva V, Barreiro S, Silva R, Remião F, Borges F, Fernandes C. Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform. Ageing Res Rev 2022;79:101658. [PMID: 35660114 DOI: 10.1016/j.arr.2022.101658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhao Y, Li L, Zhou E, Wang J, Wang Y, Guo L, Zhang X. Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications. Pharmaceutical Fronts 2022;04:e43-e60. [DOI: 10.1055/s-0042-1751036] [Reference Citation Analysis]
11 Musumeci T, Di Benedetto G, Carbone C, Bonaccorso A, Amato G, Lo Faro MJ, Burgaletto C, Puglisi G, Bernardini R, Cantarella G. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer’s Disease. Biomedicines 2022;10:985. [DOI: 10.3390/biomedicines10050985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yan Z, Yang K, Tang X, Bi Y, Ding Y, Deng M, Xia D, Zhao Y, Chen T, Wang F. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis. Journal of Immunology Research 2022;2022:1-10. [DOI: 10.1155/2022/3851604] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Szaleniec J, Gibała A, Stalińska J, Oćwieja M, Żeliszewska P, Drukała J, Szaleniec M, Gosiewski T. Pathogens in exacerbations of chronic rhinosinusitis differ in sensitivity to silver nanoparticles.. [DOI: 10.1101/2022.01.03.474872] [Reference Citation Analysis]
14 Trivedi S, Belgamwar V, Wadher K. Analytical profiling of Lentinan in hybrid nanostructures for intranasal Delivery: Method development and Validation. Results in Chemistry 2022;4:100471. [DOI: 10.1016/j.rechem.2022.100471] [Reference Citation Analysis]
15 Gugleva V, Ivanova N, Sotirova Y, Andonova V. Dermal Drug Delivery of Phytochemicals with Phenolic Structure via Lipid-Based Nanotechnologies. Pharmaceuticals (Basel) 2021;14:837. [PMID: 34577536 DOI: 10.3390/ph14090837] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]